Editorial overview Tumor immunology: present perspectives

This publication has 23 references indexed in Scilit:

• Analysis of antigens recognized on human melanoma cells by A2‐restricted cytolytic t lymphocytes (CTL)
  International Journal of Cancer, 1993
• The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
  The Journal of Experimental Medicine, 1993
• Transformation‐Associated Epstein‐Barr Virus Antigens as Targets for Immune Attacka
  Annals of the New York Academy of Sciences, 1993
• An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues.
  The Journal of Experimental Medicine, 1993
• Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells
  International Immunology, 1992
• A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
  The Journal of Experimental Medicine, 1992
• Sequential chemoimmunotherapy in the treatment of metastatic melanoma.
  Journal of Clinical Oncology, 1992
• Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells
  International Journal of Cancer, 1992
• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991
• The epstein-barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells
  International Journal of Cancer, 1991